★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★Open research. Global perspectives.
editor@theamericanjournals.comPublisher Home ↗
Medical Science OPEN ACCESS

Prognostic Significance of the Neutrophil Percentage-to-Albumin Ratio in Ischemic Stroke Mortality

Dr. Ahmed R. El-Sayed
Department of Neurology, Ain Shams University, Cairo, Egypt.
Dr. Fatima H. Mostafa
Department of Clinical Pathology,Ain Shams University, Cairo, Egypt
tajmspr 2025
VOL. 7 / NO. 06 JUNE
FULL TEXT PP. 01-08
DOWNLOAD PDF

View all articles in this issue ↗

VOLUME 7
ISSUE 06
YEAR 2025
PAGES 01-08
RESEARCH OVERVIEW

Abstract

Ischemic stroke remains a leading cause of mortality and long-term disability globally, necessitating reliable prognostic markers for effective patient management and therapeutic stratification. This article explores the emerging role of the Neutrophil Percentage-to-Albumin Ratio (NPAR) as a novel and readily accessible prognostic indicator for mortality in patients suffering from ischemic stroke. Drawing upon current literature, we delve into the intricate pathophysiology of ischemic stroke, emphasizing the dual roles of inflammation (mediated by neutrophils) and protective mechanisms (attributed to albumin). The discussion highlights how an elevated NPAR reflects a heightened pro-inflammatory state and diminished antioxidant capacity, both detrimental in the acute phase of stroke. Evidence from various cardiovascular and critical illness contexts, alongside specific findings in ischemic stroke, supports NPAR's utility in predicting not only mortality but also stroke-associated infections and poor functional outcomes. This review synthesizes the current understanding of NPAR's predictive power, its underlying biological mechanisms, and discusses its potential clinical implications, while acknowledging the need for further large-scale prospective studies to validate its widespread application in clinical practice.

RESEARCH TOPICS

Keywords

Prognostic significance neutrophil percentage-to-albumin ratio ischemic stroke stroke mortality

Downloads

Download data is not yet available.
SOURCES & SCHOLARSHIP

References

  1. Venketasubramanian N, Yoon BW, Pandian J, Navarro JC. Stroke Epidemiology in South, East, and South-East Asia: A Review. J Stroke. 2017;19:286-94
  2. Nguyen TN, Abdalkader M, Fischer U, Qiu Z, Nagel S, Chen HS. et al. Endovascular management of acute stroke. Lancet. 2024;404:1265-78
  3. Bateman RM, Sharpe MD, Jagger JE, Ellis CG, Solé-Violán J, López-Rodríguez M. et al. 36th International Symposium on Intensive Care and Emergency Medicine: Brussels, Belgium. 15-18 March 2016. Crit Care. 2016;20:94
  4. Kortelainen S, Curtze S, Martinez-Majander N, Raj R, Skrifvars MB. Acute ischemic stroke in a university hospital intensive care unit: 1-year costs and outcome. Acta Anaesthesiol Scand. 2022;66:516-25
  5. Schilling M, Strecker JK, Schäbitz WR, Ringelstein EB, Kiefer R. Effects of monocyte chemoattractant protein 1 on blood-borne cell recruitment after transient focal cerebral ischemia in mice. Neuroscience. 2009;161:806-12
  6. Cai W, Liu S, Hu M, Huang F, Zhu Q, Qiu W. et al. Functional Dynamics of Neutrophils After Ischemic Stroke. Transl Stroke Res. 2020;11:108-21
  7. Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett. 2008;582:1783-7
  8. Bourdon E, Blache D. The importance of proteins in defense against oxidation. Antioxid Redox Signal. 2001;3:293-311
  9. Parkkinen J, Ojala P, Niiranen J, Jolkkonen J. Molecular mechanisms underlying neuroprotective effects of albumin after ischemic stroke. Stroke. 2007;38:255 author reply 6
  10. Zhao Z, Zhang J, Jiang X, Wang L, Yin Z, Hall M. et al. Is Endovascular Treatment Still Good for Ischemic Stroke in Real World? A Meta-Analysis of Randomized Control Trial and Observational Study in the Last Decade. Stroke. 2020;51:3250-63
  11. Garcia-Bonilla L, Shahanoor Z, Sciortino R, Nazarzoda O, Racchumi G, Iadecola C. et al. Analysis of brain and blood single-cell transcriptomics in acute and subacute phases after experimental stroke. Nat Immunol. 2024;25:357-70
  12. Tang C, Wang C, Zhang Y, Xue L, Li Y, Ju C. et al. Recognition, Intervention, and Monitoring of Neutrophils in Acute Ischemic Stroke. Nano Lett. 2019;19:4470-7
  13. Eckart A, Struja T, Kutz A, Baumgartner A, Baumgartner T, Zurfluh S. et al. Relationship of Nutritional Status, Inflammation, and Serum Albumin Levels During Acute Illness: A Prospective Study. Am J Med. 2020;133:713-22.e7
  14. Zhao M, Huang X, Zhang Y, Wang Z, Zhang S, Peng J. Predictive value of the neutrophil percentage-to-albumin ratio for coronary atherosclerosis severity in patients with CKD. BMC Cardiovasc Disord. 2024;24:277
  15. Xu Y, Lin Z, Zhu C, Song D, Wu B, Ji K. et al. The Neutrophil Percentage-to-Albumin Ratio is Associated with All-Cause Mortality in Patients with Atrial Fibrillation: A Retrospective Study. J Inflamm Res. 2023;16:691-700
  16. Hu Z, Wang J, Xue Y, Zhang Q, Xu Q, Ji K. et al. The Neutrophil-to-Albumin Ratio as a New Predictor of All-Cause Mortality in Patients with Heart Failure. J Inflamm Res. 2022;15:701-13
  17. Lin Y, Lin Y, Yue J, Zou Q. The neutrophil percentage-to-albumin ratio is associated with all-cause mortality in critically ill patients with acute myocardial infarction. BMC Cardiovasc Disord. 2022;22:115
  18. Yu Y, Liu Y, Ling X, Huang R, Wang S, Min J. et al. The Neutrophil Percentage-to-Albumin Ratio as a New Predictor of All-Cause Mortality in Patients with Cardiogenic Shock. Biomed Res Int. 2020;2020:7458451
  19. Yang D, Niu C, Li P, Du X, Zhao M, Jing W. Study of the neutrophil percentage-to-albumin ratio as a biomarker for predicting recurrence of first-episode ischemic stroke. J Stroke Cerebrovasc Dis. 2024;33:107485
  20. Zhang H, Wu T, Tian X, Lyu P, Wang J, Cao Y. High Neutrophil Percentage-To-Albumin Ratio Can Predict Occurrence of Stroke-Associated Infection. Front Neurol. 2021;12:705790
  21. Xu S, Sun Y, Zhang S, Peng Y, Dai D, Zhao L. Relationship of Neutrophil Percentage-to-Albumin Ratio with Stroke: Evidence from NHANES 1999-2020. Brain Behav. 2024;14:e70192
  22. Lv XN, Shen YQ, Li ZQ, Deng L, Wang ZJ, Cheng J. et al. Neutrophil percentage to albumin ratio is associated with stroke-associated pneumonia and poor outcome in patients with spontaneous intracerebral hemorrhage. Front Immunol. 2023;14:1173718
  23. Borgoni S, Kudryashova KS, Burka K, de Magalhães JP. Targeting immune dysfunction in aging. Ageing Res Rev. 2021;70:101410
  24. Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16:626-38
  25. Przykaza Ł. Understanding the Connection Between Common Stroke Comorbidities, Their Associated Inflammation, and the Course of the Cerebral Ischemia/Reperfusion Cascade. Front Immunol. 2021;12:782569
  26. Gawaz M, Geisler T, Borst O. Current concepts and novel targets for antiplatelet therapy. Nat Rev Cardiol. 2023;20:583-99
  27. Levi M, van der Poll T. Coagulation and sepsis. Thromb Res. 2017;149:38-44
  28. Soppert J, Lehrke M, Marx N, Jankowski J, Noels H. Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting. Adv Drug Deliv Rev. 2020;159:4-33
  29. Strecker JK, Schmidt A, Schäbitz WR, Minnerup J. Neutrophil granulocytes in cerebral ischemia - Evolution from killers to key players. Neurochem Int. 2017;107:117-26
  30. Jickling GC, Liu D, Ander BP, Stamova B, Zhan X, Sharp FR. Targeting neutrophils in ischemic stroke: translational insights from experimental studies. J Cereb Blood Flow Metab. 2015;35:888-901
  31. Perez-de-Puig I, Miró-Mur F, Ferrer-Ferrer M, Gelpi E, Pedragosa J, Justicia C. et al. Neutrophil recruitment to the brain in mouse and human ischemic stroke. Acta Neuropathol. 2015;129:239-57
  32. Prestigiacomo CJ, Kim SC, Connolly ES Jr, Liao H, Yan SF, Pinsky DJ. CD18-mediated neutrophil recruitment contributes to the pathogenesis of reperfused but not nonreperfused stroke. Stroke. 1999;30:1110-7
  33. Bucci T, Pastori D, Pignatelli P, Ntaios G, Abdul-Rahim AH, Violi F. et al. Albumin Levels and Risk of Early Cardiovascular Complications After Ischemic Stroke: A Propensity-Matched Analysis of a Global Federated Health Network. Stroke. 2024;55:604-12
  34. Dziedzic T, Pera J, Slowik A, Gryz-Kurek EA, Szczudlik A. Hypoalbuminemia in acute ischemic stroke patients: frequency and correlates. Eur J Clin Nutr. 2007;61:1318-22
  35. Babu MS, Kaul S, Dadheech S, Rajeshwar K, Jyothy A, Munshi A. Serum albumin levels in ischemic stroke and its subtypes: correlation with clinical outcome. Nutrition. 2013;29:872-5
  36. Gao J, Zhao Y, Du M, Guo H, Wan T, Wu M. et al. Serum Albumin Levels and Clinical Outcomes Among Ischemic Stroke Patients Treated with Endovascular Thrombectomy. Neuropsychiatr Dis Treat. 2021;17:401-11
  37. Yang X, Wang L, Zheng L, Wu J, Liu J, Hao Z. et al. Serum Albumin as a Potential Predictor of Pneumonia after an Acute Ischemic Stroke. Curr Neurovasc Res. 2020;17:385-93
  38. Xu M, Huan J, Zhu L, Xu J, Song K. The neutrophil percentage-to-albumin ratio is an independent risk factor for poor prognosis in peritoneal dialysis patients. Ren Fail. 2024;46:2294149